TRENDS IN CELL AND GENE THERAPY UPTAKE AND UTILIZATION IN THE UNITED STATES: A REAL-WORLD ANALYSIS OF THE KOMODO HEALTHCARE MAP™ CLAIMS DATA FROM 2015-2021

被引：0
作者：
Oak, B. [1 ]
Silber, A. [2 ]
Goldman, E. [1 ]
Liu, R. [1 ]
Verma, D. [3 ]
Francis, K. [1 ]
Hadker, N. [1 ]
机构：
[1] Trinity Life Sci, Waltham, MA USA
[2] Trinity Partners LLC, Waltham, MA USA
[3] Trinity Life Sci, Gurgaon, MA, India
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD93
引用
收藏
页码：S594 / S594
页数：1
相关论文
共 50 条
  • [31] The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data
    Waters, Heidi C.
    Stellhorn, Robert
    Touya, Maelys
    Fitzgerald, Heather
    Bhattacharjee, Sandipan
    Citrome, Leslie
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 316 - 325
  • [32] Rituximab Use in Relapsed Indolent B-Cell Lymphoma: Real-World Data (RWD) Analysis Using Healthcare Claims Databases
    Said, Qayyim
    Khan, Nasreen
    Zong, Jihong
    Chen, Guifang
    Healy, Dennis P.
    Reddy, Sanjeeva
    BLOOD, 2022, 140 : 11970 - 11971
  • [33] Creating a Real-World Data, United States Healthcare Claims-Based Adaptation of Kurtzke Functional Systems Scores for Assessing Multiple Sclerosis Severity and Progression
    Truong, Chi T. L.
    Le, Hoa V.
    Kamauu, Aaron W.
    Holmen, John R.
    Fillmore, Christopher L.
    Kobayashi, Monica G.
    Wong, Schiffon L.
    ADVANCES IN THERAPY, 2021, 38 (09) : 4786 - 4797
  • [34] Creating a Real-World Data, United States Healthcare Claims-Based Adaptation of Kurtzke Functional Systems Scores for Assessing Multiple Sclerosis Severity and Progression
    Chi T. L. Truong
    Hoa V. Le
    Aaron W. Kamauu
    John R. Holmen
    Christopher L. Fillmore
    Monica G. Kobayashi
    Schiffon L. Wong
    Advances in Therapy, 2021, 38 : 4786 - 4797
  • [35] Real-World Disease Burden and Healthcare Resource Utilization Among Patients with COPD and Asthma Using Triple Therapy (FF/UMEC/VI) in the United States
    Igboekwe, Emmeline
    Verma, Sumit
    Paczkowski, Rosirene
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 281 - 296
  • [36] Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data
    Danese, Mark D.
    Reyes, Carolina M.
    Gleeson, Michelle L.
    Halperin, Marc
    Skettino, Sandra L.
    Mikhael, Joseph
    MEDICAL CARE, 2016, 54 (04) : 343 - 349
  • [37] Real-World Switching Pattern, Persistence, and Associated Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States
    Shah, Bijal D.
    Xue, Mei
    Furnback, Wesley
    Esselman, Kaitlyn
    Chuang, Po-Ya
    Yang, Keri
    BLOOD, 2023, 142
  • [38] Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data
    Burudpakdee, Chakkarin
    Lin, Huamao Mark
    Wang, Weiying
    Seetasith, Arpamas
    Zhu, Yanyan
    Bonthapally, Vijayveer
    Carson, Kenneth R.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (10) : 965 - 972
  • [39] UTILIZATION TRENDS AND ACCESS DISPARITIES IN CAR T-CELL THERAPY: REAL-WORLD INSIGHTS FROM AN ALL- PAYER US HEALTHCARE DATABASE (2017-2024)
    Cui, C.
    David, J.
    Curry, L.
    Moon, R.
    Rosenthal, N.
    VALUE IN HEALTH, 2024, 27 (12)
  • [40] INCREASED REAL-WORLD BIOMARKER TEST UTILIZATION IN PATIENTS WITH EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THE UNITED STATES, 2011 TO 2021
    Yan, J.
    Jin, Y.
    Lo, E.
    Chen, Y.
    Hanlon, Newell Ae
    Kong, Y.
    Inge, L.
    VALUE IN HEALTH, 2023, 26 (06) : S306 - S306
12345